Restoring type VII collagen in skin.
Journal
Med (New York, N.Y.)
ISSN: 2666-6340
Titre abrégé: Med
Pays: United States
ID NLM: 101769215
Informations de publication
Date de publication:
13 05 2022
13 05 2022
Historique:
entrez:
18
5
2022
pubmed:
19
5
2022
medline:
21
5
2022
Statut:
ppublish
Résumé
New therapeutic hope is emerging for people with the rare inherited blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB). Gurevich et al.
Identifiants
pubmed: 35584643
pii: S2666-6340(22)00174-X
doi: 10.1016/j.medj.2022.04.008
pii:
doi:
Substances chimiques
Collagen Type VII
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
273-275Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors have received educational grants from Amryt Pharma (J.A.M.) and Janssen (S.M.L.) and have undertaken paid consulting work for Replay (J.A.M.), Almirall (J.A.M.), La Roche Posay (J.A.M.), and Pierre Fabre (J.A.M.).